149 related articles for article (PubMed ID: 28643328)
1. Drug Repurposing by Simulating Flow Through Protein-Protein Interaction Networks.
Manczinger M; Bodnár VÁ; Papp BT; Bolla SB; Szabó K; Balázs B; Csányi E; Szél E; Erős G; Kemény L
Clin Pharmacol Ther; 2018 Mar; 103(3):511-520. PubMed ID: 28643328
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
3. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice.
Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H
Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
5. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
7. A review of network-based approaches to drug repositioning.
Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
[TBL] [Abstract][Full Text] [Related]
8. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning Approach for Predicting New Uses of Existing Drugs and Evaluation of Their Reliabilities.
Fukuoka Y
Methods Mol Biol; 2019; 1903():269-279. PubMed ID: 30547448
[TBL] [Abstract][Full Text] [Related]
10. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
11. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
12. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
Zhao K; So HC
IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
[TBL] [Abstract][Full Text] [Related]
14. Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
Patrick MT; Raja K; Miller K; Sotzen J; Gudjonsson JE; Elder JT; Tsoi LC
J Invest Dermatol; 2019 Mar; 139(3):683-691. PubMed ID: 30342048
[TBL] [Abstract][Full Text] [Related]
15. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
Fiscon G; Conte F; Amadio S; Volonté C; Paci P
Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
[TBL] [Abstract][Full Text] [Related]
16. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
17. PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines.
Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C
PLoS One; 2017; 12(5):e0176823. PubMed ID: 28464025
[TBL] [Abstract][Full Text] [Related]
18. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide positioning systems network algorithm for in silico drug repurposing.
Cheng F; Lu W; Liu C; Fang J; Hou Y; Handy DE; Wang R; Zhao Y; Yang Y; Huang J; Hill DE; Vidal M; Eng C; Loscalzo J
Nat Commun; 2019 Aug; 10(1):3476. PubMed ID: 31375661
[TBL] [Abstract][Full Text] [Related]
20. How good are publicly available web services that predict bioactivity profiles for drug repurposing?
Murtazalieva KA; Druzhilovskiy DS; Goel RK; Sastry GN; Poroikov VV
SAR QSAR Environ Res; 2017 Oct; 28(10):843-862. PubMed ID: 29183230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
